Aubin, 2009
Bertsekas, 1972, Infinite-time reachability of state-space regions by using feedback control, IEEE Trans. Autom. Control, 17, 604, 10.1109/TAC.1972.1100085
Bertsekas, 2009
Chesi, 2011, 415
Gilbert, 1991, Linear systems with state and control constraints: The theory and application of maximal output admissible sets, IEEE Trans. Autom. Control, 36, 1008, 10.1109/9.83532
Kolmanovsky, 1998, Theory and computation of disturbance invariant sets for discrete-time linear systems, Math. Probl. Eng., 4, 317, 10.1155/S1024123X98000866
Raković, 2005, Invariant approximations of the minimal robust positively invariant set, IEEE Trans. Autom. Control, 50, 406, 10.1109/TAC.2005.843854
Magni, 2001, A stabilizing model-based predictive control algorithm for nonlinear systems, Automatica, 37, 1351, 10.1016/S0005-1098(01)00083-8
Alamo, 2009, Convex invariant sets for discrete-time Lur’e systems, Automatica, 45, 1066, 10.1016/j.automatica.2008.11.013
Fiacchini, 2010, On the computation of convex robust control invariant sets for nonlinear systems, Automatica, 46, 1334, 10.1016/j.automatica.2010.05.007
Blanchini, 2008
Fiacchini, 2010
Fiacchini, 2012, Invariant sets computation for convex difference inclusions systems, Syst. Control Lett., 61, 819, 10.1016/j.sysconle.2012.04.012
Aubin, 2012, 264
Riah, 2015, Invariance-based analysis of cancer chemotherapy, 1111
Swan, 1990, Role of optimal control theory in cancer chemotherapy, Math. Biosci., 101, 237, 10.1016/0025-5564(90)90021-P
Martin, 1992, Optimal control drug scheduling of cancer chemotherapy, Automatica, 28, 1113, 10.1016/0005-1098(92)90054-J
De Pillis, 2006, Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations, J. Theor. Biol., 238, 841, 10.1016/j.jtbi.2005.06.037
Matveev, 2002, Application of optimal control theory to analysis of cancer chemotherapy regimens, Syst. Control Lett., 46, 311, 10.1016/S0167-6911(02)00134-2
De Pillis, 2007, Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls, Math. Biosci., 209, 292, 10.1016/j.mbs.2006.05.003
Ledzewicz, 2008, Optimal control for combination therapy in cancer, 1537
Chareyron, 2009, Mixed immunotherapy and chemotherapy of tumors: Feedback design and model updating schemes, J. Theor. Biol., 258, 444, 10.1016/j.jtbi.2008.07.002
Alamir, 2014, Robust feedback design for combined therapy of cancer, Opt. Control Appl. Methods, 35, 77, 10.1002/oca.2057
M. Alamir, On probabilistic certification of combined cancer therapies using strongly uncertain models, arXiv:1502.06218 (2015).
Afenya, 1996, Acute leukemia and chemotherapy: a modeling viewpoint, Math. Biosci., 138, 79, 10.1016/S0025-5564(96)00086-7
Afenya, 1998, Some perspectives on modeling leukemia, Math. Biosci., 150, 113, 10.1016/S0025-5564(98)10005-6
Hahnfeldt, 1999, Tumor development under angiogenic signaling a dynamical theory of tumor growth, treatment response, and postvascular dormancy, Cancer Res., 59, 4770
De Pillis, 2001, A mathematical tumor model with immune resistance and drug therapy: an optimal control approach, Comput. Math. Methods Med., 3, 79
Murray, 1994, Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle, Math. Biosci., 123, 183, 10.1016/0025-5564(94)90011-6
Riah, 2016, Domain of attraction estimation of cancer chemotherapy model affected by state proportional uncertainty, 2133
Rockafellar, 1970
Boyd, 2004